arrow
S

Steffen Maßberg

LMU Klinikum
H指数:100
被引数:4.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Splenic regulation of systemic platelet activation state

脾脏对系统性血小板活化状态的调控

Science
IF45.8
2026-09-170
PRE
Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial

使用强效抗血小板抑制剂双重抗栓治疗心房颤动和急性冠脉综合征: 一项随机对照试验

2026-08-290
OA
Timely hospital discharge in TAVI patients: towards a patient-centered care pathway

TAVI患者的及时出院:迈向以患者为中心的护理路径

2026-05-280
OAAI
Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis

作者更正:AIM2炎性小体在克隆性造血中加剧动脉粥样硬化

Nature
IF48.5
2026-05-140
PRE
Guided De-escalation of Antiplatelet Treatment in Patients at High Atherothrombotic Risk Presenting With Acute Coronary Syndrome: A Post-Hoc Analysis of the TROPICAL-ACS trial
2025-12-260
PRE
Catheter-based left atrial appendage CLOSURE in patients with Atrial Fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial

经导管左心耳闭合术在具有卒中及出血高风险的房颤患者中的应用,与最佳药物治疗比较:前瞻性随机CLOSURE-AF试验的方案与设计

2025-09-120
PRE
Fulminant myocarditis: outcome predictors in an international cohort study

暴发性心肌炎:国际队列研究中的结局预测因素

2025-09-011
PRE
Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial

经导管或手术治疗主动脉瓣狭窄的性别特异性结局:DEDICATE-DZHK6试验

2025-09-012
PRE
Cardiac disease in patients with vasculitis

血管炎患者的心脏疾病

2025-08-250
OAAI
Rationale and design of the TRIC-I-HF-DZHK24 (TRICuspid Intervention in Heart Failure) trial

TRIC-I-HF-DZHK24(心力衰竭三尖瓣干预)试验的原理与设计

2025-08-110
OAAI